165 related articles for article (PubMed ID: 23989967)
1. Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.
De Bruyne P; De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
Eur J Pediatr; 2014 Feb; 173(2):223-8. PubMed ID: 23989967
[TBL] [Abstract][Full Text] [Related]
2. Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics.
Dossche L; Michelet R; De Bruyne P; Van Herzeele C; Gasthuys E; Rittig S; Vermeulen A; Vande Walle J
Arch Dis Child; 2021 Jun; 106(6):597-602. PubMed ID: 32737054
[TBL] [Abstract][Full Text] [Related]
3. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
[TBL] [Abstract][Full Text] [Related]
4. Effects of Food and Pharmaceutical Formulation on Desmopressin Pharmacokinetics in Children.
Michelet R; Dossche L; De Bruyne P; Colin P; Boussery K; Vande Walle J; Van Bocxlaer J; Vermeulen A
Clin Pharmacokinet; 2016 Sep; 55(9):1159-70. PubMed ID: 27106176
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.
Juul KV; Van Herzeele C; De Bruyne P; Goble S; Walle JV; Nørgaard JP
Eur J Pediatr; 2013 Sep; 172(9):1235-42. PubMed ID: 23677249
[TBL] [Abstract][Full Text] [Related]
6. Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction.
De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
J Urol; 2011 Jun; 185(6):2308-13. PubMed ID: 21511277
[TBL] [Abstract][Full Text] [Related]
7. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study].
Lottmann H
Prog Urol; 2009 Feb; 19(2):132-8. PubMed ID: 19168019
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults.
Osterberg O; Savic RM; Karlsson MO; Simonsson US; Nørgaard JP; Walle JV; Agersø H
J Clin Pharmacol; 2006 Oct; 46(10):1204-11. PubMed ID: 16988210
[TBL] [Abstract][Full Text] [Related]
10. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
Ikeda H; Watanabe T; Isoyama K
Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
[TBL] [Abstract][Full Text] [Related]
11. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
Van de Walle J; Van Herzeele C; Raes A
Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
[TBL] [Abstract][Full Text] [Related]
12. [Desmopressin in the Treatment of Enuresis: Is Lyophilisate Superior to Tablets?].
Schulz-Jürgensen S; Feldmann B; Eggert P
Aktuelle Urol; 2016 Dec; 47(6):480-486. PubMed ID: 28006831
[No Abstract] [Full Text] [Related]
13. Desmopressin use in pediatric nocturnal enuresis patients: is there a sex difference in prescription patterns?
Schroeder MK; Juul KV; Mahler B; Nørgaard JP; Rittig S
Eur J Pediatr; 2018 Mar; 177(3):389-394. PubMed ID: 29260376
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditions.
Li X; Zhang H; Zhu X; Li C; Chen H; Liu J; Chen G; Wu M; Liu C; Shen Z; Niu J; Liu B; Ding Y
Int J Clin Pharmacol Ther; 2018 Sep; 56(9):434-442. PubMed ID: 30049304
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
[TBL] [Abstract][Full Text] [Related]
17. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
[TBL] [Abstract][Full Text] [Related]
18. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
[TBL] [Abstract][Full Text] [Related]
19. Focus on desmopressin and enuresis: a review of literature.
Ferrara P; Vena F; Basile MC; Ianniello F; Gatto A
Minerva Urol Nefrol; 2016 Feb; 68(1):14-9. PubMed ID: 24990391
[TBL] [Abstract][Full Text] [Related]
20. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
Robson WL; Leung AK; Norgaard JP
J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]